Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201209119 Principal Investigator: Ademuyiwa, Foluso
Title: A randomized, double-blind, placebo controlled, phase II study of BKM120 plus paclitaxel in patients with HER2 negative inoperable locally advanced or metastatic breast cancer, with or without PI3K pathway activation
Phase: II Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to compare the benefit and the safety profile of a combination of the investigational treatment BKM120 plus paclitaxel against paclitaxel plus placebo in patients with locally advanced or metastatic breast cancer.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)